Is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 still in force?

Yes — PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is currently in force.

When did PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 take effect?

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 was first recorded in 2015.

How many sections does PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 have?

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 contains 2 sections.

Where can I read the official version of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015?

The official text of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is published at lom.agc.gov.my.

/akn/my/act/pua/2015/17

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Open source PDF

Type: P.U. (A)
Status: In force
Enacted: 2015
Sections: 2

Quick answer

About this p.u. (a)

PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is Malaysia P.U. (A), cited as P.U. (A) 17 2015, currently marked in force and first recorded in 2015.

Opening note

Preamble

PADA menjalankan kuasa yang diberikan oleh seksyen 6 Akta Racun 1952 [Akta 366], Menteri, selepas berunding dengan Lembaga Racun, membuat perintah yang berikut: Nama

Seksyen 1

Perintah ini bolehlah dinamakan Perintah Racun (Pindaan Senarai Racun) 2015.

Seksyen 2

Pindaan Jadual Pertama

(a)

dalam Senarai Racun—

(i)

dengan menggantikan butiran “Abrisentan” dengan butiran “Ambrisentan”;

(ii)

dengan memasukkan selepas butiran “Alphadolone acetate” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Bahagian I

Part I

Bahagian II

Part II

Exempt

Group A

Group B

Group C

Group D

“Alpha-Phenylacetoacetonitrile

(APAAN)

All preparations”;

(iii)

dengan menggantikan butiran “Amilsulpride” dengan butiran “Amisulpride”;

(iv)

dengan menggantikan butiran “Anistreplace” dengan butiran “Anistreplase”;

(v)

dalam butiran “Antihistamines; the following:”—

dengan menggantikan butiran “Dimenhydramine” dengan butiran “Dimenhydrinate”; dan dengan menggantikan butiran “Levocetrizine” dengan butiran “Levocetirizine”;

(vi)

dengan menggantikan butiran “Calcium polysterene” dengan butiran “Calcium polystyrene”;

(vii)

dengan memasukkan selepas butiran “Camylofine; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Canakinumab

All preparations”;

(viii)

dengan memasukkan selepas butiran “Cerivastatin; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Certolizumab

All preparations”;

(ix)

dengan memasukkan selepas butiran “2, 5-Dimethoxy-4-ethylamphetamine (DOET) (DD)” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“1,3-Dimethylamylamine

(DMAA)

All preparations”;

(x)

dengan memasukkan selepas butiran “Dinitrothymols” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Diphenidol hydrochloride

All preparations”;

(xi)

dengan memotong butiran “Fexofenadine; its salt” dan butir-butir yang berhubungan dengannya;

(xii)

dengan memasukkan selepas butiran “Gallamine; its salts; its quarternary compounds” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Gamma Butyrolactone

All preparations unless exempted

When use as food additive in food”;

(xiii)

dengan memasukkan selepas butiran “Indomethacin; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Infliximab

All preparations”;

(xiv)

dengan menggantikan butiran “Lanthanum” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Lanthanum carbonate

All preparations for therapeutic use”;

(xv)

dengan memasukkan selepas butiran “Mipomersen sodium” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Mirabegron

All preparations”;

(xvi)

dalam butiran “Natamycin”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Natamycin

All preparations unless exempted

Natamycin when use as food additive in food”;

(xvii)

dalam butiran “Potassium hydroxide”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

12% and over unless exempted

Under 12%, accumulators, batteries or when use as food additive in food”;

(xviii)

dalam butiran “Sodium hydroxide”, dengan menggantikan butir-butir yang berhubungan dengannya dengan butir-butir yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

All preparations for therapeutic or diagnostic use

All preparations containing 12% and over other than those in Part I or exempted and subject to the provisions of Poisons

(Sodium Hydroxide)

Regulations 1962

Under 12%; sodium hydroxide when use as food additive in food”;

(xix)

dengan memotong butiran “Terfenadine” dan butir-butir yang berhubungan dengannya; dan

(xx)

dengan memasukkan selepas butiran “Todrazoline; its salts” dan butir-butir yang berhubungan dengannya butiran yang berikut:

Names

Exempt

Group A

Group B

Group C

Group D

“Tofacitinib

All preparations”; dan 8

(b)

dalam Lampiran kepada Senarai Racun—

(i)

dalam senarai “Anticholinergics:”—

dengan memasukkan selepas butiran “Diethazine; its salts” butiran “Diphenidol hydrochloride”; dan dengan memasukkan selepas butiran “Methixene; its salts” butiran “Mirabegron”;

(ii)

dalam senarai “Antihistamines:”—

dengan memasukkan selepas butiran “3-Dibutylaminoethyl-4, 5, 6-trihydroxy-1-isobenzofuranone” butiran

“Dimenhydrinate”; dan dengan menggantikan butiran “Levocetrizine” dengan butiran “Levocetirizine”;

(iii)

dalam senarai “Antineoplastic agents and Immunosuppressants:”—

dengan memasukkan selepas butiran “Cabazitaxel” butiran “Canakinumab”;

dengan memasukkan selepas butiran “Carmustine; its salts” butiran “Certolizumab”;

(C)

dengan memasukkan selepas butiran “Idarubicin” butiran “Infliximab”; dan 9

(D)

dengan memasukkan selepas butiran “Tocilizumab” butiran “Tofacitinib”;

(iv)

dalam senarai “Cardio drugs:”—

dengan menggantikan butiran “Abrisentan” dengan butiran “Ambrisentan”; dan dengan menggantikan butiran “Anistreplace” dengan butiran “Anistreplase”;

(v)

dalam senarai “Industrial and laboratory poisons:”—

dengan memasukkan selepas butiran “Acetyl chloride” butiran “Alpha-Phenylacetoacetonitrile (APAAN)”; dan dengan memasukkan selepas butiran “Formaldehyde” butiran “Gamma Butyrolactone”;

(vi)

dalam senarai “Sympathomimetic amines:”, dengan memasukkan selepas butiran “Atomoxetine; its salts” butiran

“1,3- Dimethylamylamine (DMAA)”;

(vii)

dalam senarai “Tranquillisers:”, dengan menggantikan butiran “Amilsulpride” dengan butiran “Amisulpride”; dan

(viii)

dalam senarai “Miscellaneous:”—

dengan menggantikan butiran “Calcium polysterene” dengan butiran “Calcium polystyrene”; dan dengan menggantikan butiran “Lanthanum” dengan butiran “Lanthanum carbonate”.

Dibuat 26 Januari 2015

[KK(R)608(14); PN(PU2)172/XIII]

DATUK SERI DR. S. SUBRAMANIAM

Menteri Kesihatan

POISONS ACT 1952

POISONS (AMENDMENT OF POISONS LIST) ORDER 2015

Opening note

Preamble

IN exercise of the powers conferred by section 6 of the Poisons Act 1952 [Act 366], the Minister, after consultation with the Poisons Board, makes the following order: Citation 1. This order may be cited as the Poisons (Amendment of Poisons List) Order 2015. Amendment of First Schedule 2. The Poisons Act 1952 is amended in the First Schedule—

(a)

in the Poisons List—

(i)

by substituting for the item “Abrisentan” the item “Ambrisentan”;

(ii)

by inserting after the item “Alphadolone acetate” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Alpha-Phenylacetoacetonitrile

(APAAN)

All preparations”;

(iii)

by substituting for the item “Amilsulpride” the item “Amisulpride”;

(iv)

by substituting for the item “Anistreplace” the item “Anistreplase”;

(v)

in the item “Antihistamines; the following:”—

by substituting for the item “Dimenhydramine” the item “Dimenhydrinate”; and by substituting for the item “Levocetrizine” the item “Levocetirizine”;

(vi)

by substituting for the item “Calcium polysterene” the item “Calcium polystyrene”;

(vii)

by inserting after the item “Camylofine; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Canakinumab

All preparations”;

(viii)

by inserting after the item “Cerivastatin; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Certolizumab

All preparations”;

(ix)

by inserting after the item “2, 5-Dimethoxy-4-ethylamphetamine (DOET) (DD)” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“1,3-Dimethylamylamine

(DMAA)

All preparations”;

(x)

by inserting after the item “Dinitrothymols” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Diphenidol hydrochloride

All preparations”;

(xi)

by deleting the item “Fexofenadine; its salt;” and the particulars relating to it;

(xii)

by inserting after the item “Gallamine; its salts; its quarternary compounds” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Gamma Butyrolactone

All preparations unless exempted

When use as food additive in food”;

(xiii)

by inserting after the item “Indomethacin; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Infliximab

All preparations”;

(xiv)

by substituting for the item “Lanthanum” and the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Lanthanum carbonate

All preparations for therapeutic use”;

(xv)

by inserting after the item “Mipomersen sodium” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Mirabegron

All preparations”;

(xvi)

in the item “Natamycin”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Natamycin

All preparations unless exempted

Natamycin when use as food additive in food”;

(xvii)

in the item “Potassium hydroxide”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Potassium hydroxide

12% and over unless exempted

Under 12%, accumulators, batteries or when use as food additive in food”;

(xviii)

in the item “Sodium hydroxide”, by substituting for the particulars relating to it the following particulars:

Names

Exempt

Group A

Group B

Group C

Group D

“Sodium hydroxide

All preparations for therapeutic or diagnostic use

All preparations containing 12% and over other than those in

Part I or exempted and subject to the provisions of Poisons

(Sodium Hydroxide)

Regulations 1962

Under 12%; sodium hydroxide when use as food additive in food”;

(xix)

by deleting the item “Terfenadine” and the particulars relating to it; and

(xx)

by inserting after the item “Todrazoline; its salts” and the particulars relating to it the following item:

Names

Exempt

Group A

Group B

Group C

Group D

“Tofacitinib

All preparations”;

and

(b)

in the Appendix to the Poisons List—

(i)

in the list of “Anticholinergics:”—

by inserting after the item “Diethazine; its salts” the item “Diphenidol hydrochloride”; and by inserting after the item “Methixene; its salts” the item “Mirabegron”;

(ii)

in the list of “Antihistamines:”—

by inserting after the item “3-Dibutylaminomethyl-4, 5, 6-trihydroxy-1-isobenzofuranone” the item

“Dimenhydrinate”; and by substituting for the item “Levocetrizine” the item “Levocetirizine”;

(iii)

in the list of “Antineoplastic agents and Immunosuppressants:”—

by inserting after the item “Cabazitaxel” the item “Canakinumab”;

by inserting after the item “Carmustine; its salts” the item “Certolizumab”;

(C)

by inserting after the item “Idarubicin” the item “Infliximab”; and

(D)

by inserting after the item “Tocilizumab” the item “Tofacitinib”;

(iv)

in the list of “Cardio drugs:”—

by substituting for the item “Abrisentan” the item “Ambrisentan”; and by substituting for the item “Anistreplace” the item “Anistreplase”;

(v)

in the list of “Industrial and laboratory poisons:”—

by inserting after the item “Acetyl chloride” the item “Alpha-Phenylacetoacetonitrile (APAAN)”; and by inserting after the item “Formaldehyde”, the item “Gamma Butyrolactone”;

(vi)

in the list of “Sympathomimetic amines:”, by inserting after the item “Atomoxetine; its salts” the item

“1,3- Dimethylamylamine (DMAA)”;

(vii)

in the list of “Tranquillisers:”, by substituting for the item “Amilsulpride” the item “Amisulpride”; and

(viii)

in the list of “Miscellaneous:”—

by substituting for the item “Calcium polysterene” the item “Calcium polystyrene”; and by substituting for the item “Lanthanum” the item “Lanthanum carbonate”.

Made 26 January 2015

[KK(R)608(14); PN(PU2)172/XIII]

DATUK SERI DR. S. SUBRAMANIAM

Minister of Health

Common questions

What is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is Malaysia P.U. (A), cited as P.U. (A) 17 2015, currently marked in force and first recorded in 2015.
Is PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 still in force?: Yes — PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is currently in force.
When did PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 take effect?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 was first recorded in 2015.
How many sections does PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 have?: PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 contains 2 sections.
Where can I read the official version of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015?: The official text of PERINTAH RACUN (PINDAAN SENARAI RACUN) 2015 is published at lom.agc.gov.my.